Fundraising Fox

Aquestive Therapeutics

NASDAQ: AQST

Warren, US · Delaware corporation · 150 employees on LinkedIn

Biotech

Founders & leadership

KJ
Keith J KendallChief Executive Officer
AM
A. Mark ShobelChief Operating Officer
TW
Theresa WoodVice President, Human Resources
PB
Peter BoydVice President, Value Delivery
DB
Daniel BarberVice President, Business and Product Development
JT
John T MaxwellChief Financial Officer, Treasurer, Secretary
GB
Gregory BrownNamed on SEC filing
DB
Douglas BrattonNamed on SEC filing
JC
John CochranNamed on SEC filing
SC
Santo CostaNamed on SEC filing
JS
James S ScibettaNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.1M disclosed across 1 round · 2018

▶$9.1MraisedMay 2018 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory BrownDirector
  • Keith J KendallExecutive Officer, Director
  • A. Mark ShobelExecutive Officer, Director
  • Theresa WoodExecutive Officer
  • Douglas BrattonDirector
  • John CochranDirector
  • Santo CostaDirector
  • Peter BoydExecutive Officer
  • James S ScibettaDirector
  • Daniel BarberExecutive Officer
  • John T MaxwellExecutive Officer
Offering amount
$9.1M
Amount sold
$9.1M
Minimum investment
$100
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Aquestive Therapeutics raised?
Aquestive Therapeutics has disclosed $9.1M raised across 1 round.
Where is Aquestive Therapeutics headquartered?
Aquestive Therapeutics is headquartered in Warren, US.